The survey reveals how financial anxiety has become an everyday occurrence affecting everyday health through stress, ...

GSK sponsors the 2025 National Senior Games to raise awareness about RSV risks and prevention for older adults through ...

The newly formed biotech launches with five promising autoimmune candidates, $300 million in funding, and leadership from ...

Effective August 7, 2025, Maziar Mike Doustdar will succeed Lars Fruergaard Jørgensen as Novo Nordisk president and chief ...

The restructuring includes the elimination of certain roles and a reduction in the company’s global real estate footprint.

Pharmaceutical Executive delivers strategic insights for pharma leaders, covering commercialization, market access, R&D, and ...

The extended review for Elinzanetant is supported by data from the Phase III OASIS 1, 2, and 3 trials, which supported the ...

Hengrui Pharma partners with GSK to develop 12 innovative medicines, enhancing COPD treatment and expanding global growth ...

Neha Anand, Analyst, Biopharma Intelligence Services, Citeline, explains how positive Phase III results for Emrelis may position AbbVie as a key player in MET-high non-small cell lung cancer, ...

While MSN reports that Sarepta’s stock price began to rise on Monday on the heels of the announcement, 5 the company is still facing challenges. Shipments of the gene therapy for non-ambulatory ...

AI influencers represent the cutting edge of digital storytelling. But when applied to pharmaceutical marketing, innovation must be balanced with integrity.

John Showalter, MD, MSIS, chief operating officer at Linus Health, added, “We've built our platform to be embedded ...